Primaquine, an 8-aminoquinoline drug capable of clearing the intra-hepatic schizonts, hypnozoites of Plasmodium vivax, and holds a unique and unreplaceable radical cure, but the non-compliance with 14 day-course primaquine regimen is a big problem now.
Scientists have developed a new drug capsule that remains in the stomach for up to two weeks after being swallowed, gradually releasing its payload, paving the way for a long acting pill that may effectively treat malaria and many other diseases.
Australian military veterans are vowing to redouble their effort to win a battle against the Defence Force over trials of a controversial anti-malaria drug.